Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crely is a private medtech and digital health company developing an AI-enabled clinical decision support platform for the early detection and prediction of surgical site infections. Its core offering combines a non-invasive wearable sensor patch with software that continuously monitors patient biomarkers and integrates clinical risk factors to support remote postoperative surveillance. The company focuses on reducing readmissions and improving outcomes by identifying infection risk after hospital discharge, when many surgical site infections are first detected. Crely appears to operate as an early-stage healthcare technology company serving hospitals and care organizations rather than as a therapeutics developer. Publicly available information suggests a narrow product focus centered on postoperative infection monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crely Healthcare.